| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/20/2003 | WO2003013438A2 Nutrient therapy for immuno-compromised patients |
| 02/20/2003 | WO2003013434A2 Methods and compositions for treating diseases associated with excesses in ace |
| 02/20/2003 | WO2003013432A2 Methods of use for novel sulfur containing organic nitrate compounds |
| 02/20/2003 | WO2003013427A2 A method for preparing fluticasone derivatives |
| 02/20/2003 | WO2003013424A2 Use of r-nsaid compounds for anti-hiv treatment |
| 02/20/2003 | WO2002085368A3 Use of radical scavenging compounds for treatment and prevention of no-dependent microcirculation disorders |
| 02/20/2003 | WO2002085291A3 Nociceptin analogs |
| 02/20/2003 | WO2002079183A8 Halogenated rhodamine derivatives and applications thereof |
| 02/20/2003 | WO2002074742A3 Cdk-inhibitory indirubin derivatives having an increased solubility |
| 02/20/2003 | WO2002074331A3 Mutated mhc molecules for use in immune suppression |
| 02/20/2003 | WO2002072585A3 Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 02/20/2003 | WO2002072019A3 Interferon-beta polynucleotide therapy for autoimmune and inflammatory diseases |
| 02/20/2003 | WO2002072003A3 Use of steroid derivatives for the treatment of a benighn and/or malignant tumour |
| 02/20/2003 | WO2002069904A3 Cd2 antagonists for treatment of autoimmune or inflammatory disease |
| 02/20/2003 | WO2002053170A3 Combined use of enzyme inhibitors and pharmaceutical preparations thereof for the treatment and prophylaxis of arteriosclerosis, for the treatment and prevention of allergic reactions of type i according to the gell and coombs classification, and for the treatment and prevention of dermatological diseases associated with fo |
| 02/20/2003 | WO2002049993A3 High affinity small molecule c5a receptor modulators |
| 02/20/2003 | WO2002042295A3 Peptides as met-ap2 inhibitors |
| 02/20/2003 | WO2002029088A9 Highly expressible genes |
| 02/20/2003 | WO2002026950A3 Transferases |
| 02/20/2003 | WO2002008268A3 Leucine-based motif and clostridial neurotoxins |
| 02/20/2003 | WO2001072325A9 Methods of blocking tissue destruction by autoreactive t cells |
| 02/20/2003 | WO2001022952A3 Use of tace inhibitors |
| 02/20/2003 | US20030036639 Immunizing compositions and methods of use |
| 02/20/2003 | US20030036552 Novel compounds |
| 02/20/2003 | US20030036543 Especially as inhibitors of Aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease. |
| 02/20/2003 | US20030036526 Activating a signaling cascade comprising, introducing leptin and/or a cytokine to a receptor complex comprising gp 130, to genes in neuro- endocrine cells or cells of neuro-endocrine origin. |
| 02/20/2003 | US20030036512 A neurotrophic factor, such as brain-derived neurotrophic factor; treating leptin resistance caused hypertension, sterility, obesity, glucose metabolic abnormality, ischemic disease and growth hormone insufficiency |
| 02/20/2003 | US20030036185 Novel amino acid sequences for human kidney cadherin-like polypeptides |
| 02/20/2003 | US20030036184 Polypeptides exhibiting PDE7 activity and their use for selecting compounds which inhibit PDE 7 enzyme activity |
| 02/20/2003 | US20030036075 Nucleotide sequences coding transport protein for us in the treatment and diagnosis of cancer, arthritis, vision defects and skin dsorders |
| 02/20/2003 | US20030035853 Antiinflammatory agents, analgesics; fatty acid mixture and plant extracts |
| 02/20/2003 | US20030035835 Protective overcoatings |
| 02/20/2003 | US20030035816 Soluble ctla4 mutant molecules and uses thereof |
| 02/20/2003 | US20030035810 Antiallergens |
| 02/20/2003 | US20030035808 Complexing heat shock proteins; anticancer agents |
| 02/20/2003 | US20030035801 Stimulating neutrophil function to treat inflammatory bowel disease |
| 02/20/2003 | US20030035799 Glycosylated antibody |
| 02/20/2003 | US20030035796 Novel compound for treatment of allergy and asthma |
| 02/20/2003 | US20030035793 Novel immune response targeting molecules |
| 02/20/2003 | US20030035789 Purging lymphocytes |
| 02/20/2003 | CA2607992A1 Bicyclic compound, production and use thereof |
| 02/20/2003 | CA2457624A1 Nutrient therapy for immuno-compromised patients |
| 02/20/2003 | CA2456802A1 Composite superimmunogen for bi-functional vaccine use for the treatment of illnesses associated with a stromal tissue disorder |
| 02/20/2003 | CA2456607A1 Uses of mammalian cytokine; related reagents |
| 02/20/2003 | CA2456369A1 Proteins associated with cell growth, differentiation, and death |
| 02/20/2003 | CA2456328A1 Complexes of a short cpg-containing oligonucleotide bound to the surface of a solid phase microcarrier and methods for use thereof |
| 02/20/2003 | CA2456291A1 Hydroxamic acid derivatives |
| 02/20/2003 | CA2456287A1 Anti-idiotypic antibodies of hla class i molecules and the use thereof in the preparation of compositions that are designed to inhibit vascular activation |
| 02/20/2003 | CA2456247A1 Use of il-18 inhibitors in hypersensitivity disorders |
| 02/20/2003 | CA2456144A1 A group of novel anti-cancer compounds with specific structure |
| 02/20/2003 | CA2456124A1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists |
| 02/20/2003 | CA2456103A1 Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid derivatives |
| 02/20/2003 | CA2455871A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists. |
| 02/20/2003 | CA2455759A1 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 02/20/2003 | CA2455631A1 Aminoisoxazole derivatives active as kinase inhibitors |
| 02/20/2003 | CA2453995A1 Tacis and br3 polypeptides and uses thereof |
| 02/20/2003 | CA2453433A1 Methods of use for novel sulfur containing organic nitrate compounds |
| 02/20/2003 | CA2451919A1 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 02/20/2003 | CA2451691A1 Use of r-nsaid compounds for anti-hiv treatment |
| 02/20/2003 | CA2428822A1 Modulators of p-selectin glycoprotein ligand 1 |
| 02/19/2003 | EP1284289A1 Method of examining allergic disease |
| 02/19/2003 | EP1284288A1 Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby |
| 02/19/2003 | EP1284266A1 Novel indole derivatives exhibiting chymase-inhibitory activities and process for preparation thereof |
| 02/19/2003 | EP1284265A1 Benzothiophene derivatives and medicinal use thereof |
| 02/19/2003 | EP1284263A1 Derivatives of p- hydroxy phenyl propionic acid as antiproliferative agents |
| 02/19/2003 | EP1283903A1 Drug screening systems and assays |
| 02/19/2003 | EP1283886A2 Intracellular signaling proteins |
| 02/19/2003 | EP1283882A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses |
| 02/19/2003 | EP1283874A2 Novel deoxynucleoside kinase enzyme variants |
| 02/19/2003 | EP1283869A2 Novel bee venom polypeptides and methods of use thereof |
| 02/19/2003 | EP1283849A2 Human receptor proteins; related reagents and methods |
| 02/19/2003 | EP1283848A2 Protein complexes and assays for screening anti-cancer agents |
| 02/19/2003 | EP1283835A2 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators |
| 02/19/2003 | EP1283827A2 Caspase inhibitors and uses thereof |
| 02/19/2003 | EP1283825A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 02/19/2003 | EP1283735A2 Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 02/19/2003 | EP1283725A1 Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof |
| 02/19/2003 | EP1283721A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 02/19/2003 | EP1283720A1 Recombinant or purified polyclonal antibodies for treating allergy |
| 02/19/2003 | EP1283719A2 Apoptotic agents |
| 02/19/2003 | EP0950065B1 Peptide as diagnostic and therapeutic agent for autoimmune diseases |
| 02/19/2003 | EP0920425B1 Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases |
| 02/19/2003 | EP0817786B1 Substituted tetronic acids useful for treating hiv and other retroviruses |
| 02/19/2003 | EP0774969B1 Hiv protease inhibitor combination |
| 02/19/2003 | EP0661980B1 Methods and compositions for attenuating antibody-mediated xenograft rejection in human recipients |
| 02/19/2003 | CN1398297A Recombinant flaviviruses and methods of use thereof |
| 02/19/2003 | CN1398265A 杂环酰胺衍生物 Heterocyclic amide derivatives |
| 02/19/2003 | CN1398260A 二肽腈组织蛋白酶k抑制剂 Dipeptide nitrile cathepsin inhibitors k |
| 02/19/2003 | CN1398252A Dehydroamino acids compounds |
| 02/19/2003 | CN1398187A Method and compsns. for treating liver cell cancer |
| 02/19/2003 | CN1397566A Atractylodes polyose with antineoplastic and immunoregualting functions and its preparing process and application |
| 02/19/2003 | CN1397556A Alkali-metal or alkali-earth metal salt of polyprotic acid delotadine and its medical composition |
| 02/19/2003 | CN1101814C Novel hydroxy and polyhydroxy derivatives of coumarin, prepn. thereof and antiviral action thereof |
| 02/19/2003 | CN1101813C 3-pyrazolecarboxamide derivs, having cannabinoid receptor affinity |
| 02/19/2003 | CN1101807C 异羟肟酸衍生物 Hydroxamic acid derivatives |
| 02/19/2003 | CN1101702C Compound capsules contg. granulocyte colony stimulating factor and polyose |
| 02/19/2003 | CN1101686C Medicine and feed for fishes, shellfishes and animals and medicines for plants |
| 02/18/2003 | WO2002016329A1 Novel phenylalanine derivatives |
| 02/18/2003 | US6521776 Immunological adjuvant compounds compositions and methods of use thereof |
| 02/18/2003 | US6521759 Aminothiazole inhibitors of cyclin dependent kinases |